Skip to main content
SpringerLink
Log in

Recovery of serum TSH and thyroid hormones after 3′isopropyl-3,5-diiodo-L-thyronine (DIIP) treatment: absence of inhibiting effect of bromocriptine on TSH secretion and evidence for autoregulation of serum T3 levels

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Bromocriptine, because of its dopaminergic activity, could possibly inhibit TSH secretion. This hypothesis was tested in 7 normal male volunteers. Thyroid function was suppressed with the very potent thyromimetic analogue, 3′isopropyl-3, 5-diiodo-L-thyronine (DIIP). We wanted to observe, after stopping this treatment, whether the return of serum T3, T4, rT3 and TSH values was influenced by concomitant bromocriptine treatment (5 mg/day). For comparison, the DIIP study was also performed without bromocriptine treatment. In both cases, serum T4 and serum T3, which had decreased by, respectively, 34% ± 5% and 17% ± 5%, returned over the same time interval to their initial values. Serum TSH and TRH-mediated TSH secretion were also unaffected by the bromocriptine treatment. DIIP does not interfere in the serum determination of T3, T4 and rT3. During suppression with DIIP serum T3 fell less than serum T4 and returned more rapidly to its initial concentrations. It is concluded that dopaminergic inhibition by bromocriptine, at this dose, is insufficient to alter normal thyroid function. In addition, during suppression and shortly thereafter there is a tendency for the serum T3 levels to be maintained.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkes D. Bromocriptine. N. Engl. J. Med. 301: 16, 1979.

    Google Scholar 

  2. Kebabian J., Calne D. Multiple receptors for dopamine. Nature 277: 93, 1979.

    Article  CAS  PubMed  Google Scholar 

  3. Morley J. Neuroendocrine control of thyrotropin secretion. Endocrine Rev. 2: 4, 1981.

    Article  Google Scholar 

  4. Yap P.L., Mc Davidson N. M., Lidgard G.P., Fyffe J. A. Bromocriptine suppression of thyrotropin response to thyrotropin releasing hormone. Clin. Endocrinol. (Oxf.) 9: 179, 1978.

    Article  CAS  Google Scholar 

  5. Jlikorkala O., Kivinen S., Ronnberg L., Viinikka L. Bromocriptine suppresses TSH response to TRH during human pregnancy. Clin. Endocrinol. (Oxf.) 13: 253, 1980.

    Article  Google Scholar 

  6. Kobberling J., Darracgh A., del Pozo E. Chronic dopamine receptor stimulation using bromocriptine: failure to modify thyroid function. Clin. Endocrinol. (Oxf.) 11: 367, 1979.

    Article  CAS  Google Scholar 

  7. Gharib H., Ryan R.J., Mayberry W.E., Hockert T. Radioimmunoassay for T3. Affinity and specificity of an tibody for T3. J. Clin. Endocrinol. Metab. 33: 509, 1971.

    Article  CAS  PubMed  Google Scholar 

  8. Patel J. C., Burger H.G., Hudson B. Radioimmunoassay of serum thyrotropin: sensitivity and specificity. J. Clin. Endocrinol. Metab. 33: 768, 1971.

    Article  CAS  PubMed  Google Scholar 

  9. Chopra I.J., Solomon D.H., Ho R.S. A radioimmunoassay of thyroxine. J. Clin. Endocrinol. Metab. 33: 865, 1971.

    Article  CAS  PubMed  Google Scholar 

  10. Chopra I.J., Solomon D.H., Beall G.N. Radioimmunoassay for measurement of triiodothyro nine in human serum. J. Clin. Invest. 50: 2033, 1971.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Kaiser C., Salomon-Montavon N., Merkelbach U., Burger A.G. 3′isopropyl-3, 5-diiodo-L-thyronine: a potent synthetic thyromimetic thyronine analogue. Studies of its kinetig and biological potency in man and rats, and its toxicology. J. Clin. Endocrinol. Metab. 57: 44, 1983.

    Article  CAS  PubMed  Google Scholar 

  12. Scanion M.F., Weetman A.P., Lewis M., Pourmand M., Rodriguez-Arnao D., Weightman D.R., Hall R. Dopaminergic modulation of circadian thyrotropin rhyt-mus and thyroid hormones levels in euthyroid subjects. J. Clin. Endocrinol. Metab. 56: 6, 1980.

    Google Scholar 

  13. Scanlon M.F., Weightman D.R., Shale D.J., Mora B., Heath M., Snow M.H., Lewis M., Hall R. Dopamine is a physiological regulator of thyrotropin secretion in normal man. Clin. Endocrinol. (Oxf.) 10: 7, 1979.

    Article  CAS  Google Scholar 

  14. Scanlon M.F., Weightman D.R., Mora B., Shale D.J., Heath M., Snow M.H., Hall R. Evidence for dopaminergic control of thyrotropin secretion in man. Lancet 2: 421, 1977.

    Article  CAS  PubMed  Google Scholar 

  15. Sowers J., Catania R., Hershman J. Evidence for dopaminergic control of circadian variations in thyrotropin secretion. J. Clin. Endocrinol. Metab. 54: 4, 1982.

    Google Scholar 

  16. Kaptein E.M., Spencer C., Kamiel M., Nicoloff J. T. Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J. Clin. Endocrinol. Metab. 51: 2, 1980.

    Google Scholar 

  17. Kaptein E.M., Kletzky O.A., Spencer C., Nicoloff J. T. Effect of prolonged dopamine infusion on anterior pituitary function in normal males. J. Clin. Endocrinol. Metab. 57: 2, 1980.

    Google Scholar 

  18. Kaptein E.M., Robinson W.J., Grieb D.A., Nicoloff J. T. Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the triiodothyronine low states of acute nonthyroidal illness. J. Clin. Invest. 69: 526, 1982.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Werner S.C., Ingbar S.H. The Thyroid, ed. 4. Harper and Row, Hagerstown Maryland, New-York, San Francisco, London, 1978, p. 219.

    Google Scholar 

  20. Vagenakis A.G., Koutras D.A., Burger A., Malamas B., Ingbar S.H., Braverman L.E. Studies of serum triiodothyronine, thyroxine and thyrotropine concentrations in endemic goiter in Greece. J. Clin. Endocrinol. Metab. 37: 485, 1973.

    Article  CAS  PubMed  Google Scholar 

  21. Abuid J., Larsen P.R. Triiodothyronine and thyroxine in hyperthyroidism. J. Clin. Invest. 54: 201, 1974.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Lum S.M.C., Nicoloff J. T., Spencer C., Kaptein E.M. Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man. J. Clin. Invest. 73: 570, 1984.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thyroid Research Unit, Division of Endocrinology, Department of Medicine, University of Geneva, Switzerland

    N. A. Salomon-Montavon &  A. G. Burger

  2. Unité de Thyroïde Lab. 4-767, Hôpital Cantonal, CH-1211, Geneva 4, Switzerland

    A. G. Burger

Authors
  1. N. A. Salomon-Montavon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. G. Burger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salomon-Montavon, N.A., Burger, A.G. Recovery of serum TSH and thyroid hormones after 3′isopropyl-3,5-diiodo-L-thyronine (DIIP) treatment: absence of inhibiting effect of bromocriptine on TSH secretion and evidence for autoregulation of serum T3 levels. J Endocrinol Invest 7, 501–505 (1984). https://doi.org/10.1007/BF03348457

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348457

Key-words

Search

Navigation